Anti-oxidant enzymes and related elements in term and preterm newborns

Niccolò Nassi1, Vanessa Ponziani, Matteo Becatti

  • 1Department of Paediatrics, University of Florence, Florence, Italy. nassi@scibio.unifi .it

Insights

Preterm infants, even healthy ones, show higher oxidative stress markers and lower antioxidant enzyme activity. Careful assessment of zinc and copper levels is crucial for their nutritional status.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Nutritional Science

Background:

  • Oxidative stress is a concern for extremely low birthweight neonates.
  • Healthy preterm newborns may also face oxidative damage risks.

Purpose of the Study:

  • To investigate oxidative stress and antioxidant status in preterm infants.

Main Methods:

  • Measured urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and erythrocyte glutathione peroxidase (GSHPx) and superoxide dismutase (SOD).
  • Assessed plasma and erythrocyte selenium, zinc, and copper levels in 30 preterm and 30 term infants up to 100 days.
  • Compared markers between preterm and term infants.

Main Results:

  • Preterm infants exhibited significantly higher urinary 8-OHdG, indicating increased oxidative stress.
  • Lower GSHPx activity was observed in preterm infants early on, not linked to selenium deficiency.
  • Reduced SOD levels and significantly low plasma copper concentrations were noted in preterm infants up to 100 days.

Conclusions:

  • Preterm infants, even those not extremely low birthweight, show signs of oxidative stress.
  • Nutritional status of zinc and copper, essential for antioxidant enzymes, requires careful monitoring in preterm infants.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview